Abstract: The present disclosure relates generally to the field of nutraceutical compositions. Specifically, the disclosure is directed to a nutraceutical tea composition for boosting immunity comprising Phyllanthus emblica, Tinospora cordifolia, Curcuma longa, Citrus limon, Piper nigrum, Cinnamomum verum, Syzygium aromaticum, and Zingiber officinale. The disclosure further relates to a method of preparing the nutraceutical tea composition.
[0001] The present disclosure relates generally to the field of nutraceutical compositions. Specifically, the disclosure is directed to a nutraceutical tea composition for boosting immunity comprising Phyllanthus emblica, Tinospora cordifolia, Curcuma longa, Citrus limon, Piper nigrum, Cinnamomum verum, Syzygium aromaticum, and Zingiber officinale. The disclosure also relates to a method of preparing the nutraceutical tea composition.
BACKGROUND OF THE INVENTION
[0002] Background description includes information that may be useful in understanding the present invention. It is not an admission that any of the information provided herein is prior art or relevant to the presently claimed invention, or that any publication specifically or implicitly referenced is prior art.
[0003] Immunity is the ability of an organism to resist the invasion of harmful micro-organisms. The body recognizes foreign materials as antigens and shields itself from them. These antigens may be microbes, including bacteria, virus, protozoa, or toxins. Human body is equipped with adequate immunity to fight a host of common antigens. However, a compromised immunity attracts diseases early and leaves a more damaging impact on the body. Several factors may affect the immunity of the body for example the surrounding environment, quality and nutritional value of food, lifestyle, fatigue, disease, stress, exposure to microorganisms etc. Small changes like quitting smoking, eating healthy etc., may bring about a positive effect on the immunological response.
[0004] Apart from the simple changes in lifestyle, some medications, pills and supplements have been known to provide an additional boost to immunity. However, these synthetic pills or supplements may be associated with side-effects. Additionally, the patient may find it difficult to follow a suggested therapeutic regimen decreasing patient compliance. For example, the elderly may not find it easy to swallow a pill. Tea concoctions on the other hand provide an easy method of introducing immunity boosters in the system. It’s a natural, age old technique, well rooted and treasured in traditions across the globe for promoting health. Most people are habituated to consuming a cup or two each day, making it easier to monitor the intake. However, tea is known to cause acidity or heart burn in individuals with weaker digestive systems.
[0005] Thus, there is a need in the art to develop improved compositions that satisfy the existing needs, as well as others, and generally overcome the deficiencies found in the prior art. The improved nutraceutical tea compositions of the present disclosure are natural, economic and effective immunity boosters.
OBJECTS OF THE INVENTION
[0006] An object of the present disclosure is to provide a nutraceutical tea composition that satisfies the existing needs, as well as others, and generally overcomes the deficiencies found in the prior art.
[0007] An object of the present disclosure is to provide a nutraceutical tea composition that acts as an immunity booster.
[0008] An object of the present disclosure is to provide a nutraceutical tea composition that improves respiratory health.
[0009] Another object of the present disclosure is to provide a nutraceutical tea composition that has no side effects.
[0010] Yet another object of the present disclosure is to provide a nutraceutical tea composition that is eco-friendly and easy to produce.
[0011] Still another object of the present disclosure is to provide a method for preparing a nutraceutical tea composition.
SUMMARY OF THE INVENTION
[0012] This summary is provided to introduce a selection of concepts in a simplified form that are further described below in Detailed Description section. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
[0013] The present disclosure relates to a nutraceutical tea composition. Said composition boosts the immunity of the individual. Specifically it boosts resistance towards respiratory infections and diseases.
[0014] In an aspect, the present disclosure relates to a nutraceutical tea composition for boosting immunity comprising Phyllanthus emblica, Tinospora cordifolia, Curcuma longa, Citrus limon, Piper nigrum, Cinnamomum verum, Syzygium aromaticum, and Zingiber officinale.
[0015] In an embodiment, the nutraceutical tea composition for boosting immunity may further comprise an excipient. The excipient may be selected from the group comprising of flavonoids, stabilizers, binders, flavoring agents, coloring agents, humectants, preservatives, olfactory agents, and combinations thereof.
[0016] In still another aspect, the present disclosure provides a tea bag comprising the nutraceutical tea composition and a means for packaging.
[0017] In yet another aspect, the present disclosure relates to a process of preparing a nutraceutical tea composition for boosting immunity comprising Phyllanthus emblica, Tinospora cordifolia, Curcuma longa, Citrus limon, Piper nigrum, Cinnamomum verum, Syzygium aromaticum, and Zingiber officinale.
[0018] Other aspects of the invention will be set forth in the description which follows, and in part will be apparent from the description, or may be learnt by the practice of the invention.
DETAILED DESCRIPTION OF THE INVENTION
[0019] The following is a detailed description of embodiments of the disclosure. The embodiments are in such detail as to clearly communicate the disclosure. However, the amount of detail offered is not intended to limit the anticipated variations of embodiments; on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present disclosure as defined by the appended claims.
[0020] All publications herein are incorporated by reference to the same extent as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. Where a definition or use of a term in an incorporated reference is inconsistent or contrary to the definition of that term provided herein, the definition of that term provided herein applies and the definition of that term in the reference does not apply.
[0021] Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
[0022] In some embodiments, numbers have been used for quantifying weights, percentages, ratios, and so forth, to describe and claim certain embodiments of the invention and are to be understood as being modified in some instances by the term “about.” Accordingly, in some embodiments, the numerical parameters set forth in the written description and attached claims are approximations that can vary depending upon the desired properties sought to be obtained by a particular embodiment. In some embodiments, the numerical parameters should be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of some embodiments of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as practicable. The numerical values presented in some embodiments of the invention may contain certain errors necessarily resulting from the standard deviation found in their respective testing measurements.
[0023] Various terms as used herein are shown below. To the extent a term used in a claim is not defined below, it should be given the broadest definition persons in the pertinent art have given that term as reflected in printed publications and issued patents at the time of filing.
[0024] As used in the description herein and throughout the claims that follow, the meaning of “a,” “an,” and “the” includes plural reference unless the context clearly dictates otherwise. Also, as used in the description herein, the meaning of “in” includes “in” and “on” unless the context clearly dictates otherwise.
[0025] Unless the context requires otherwise, throughout the specification which follow, the word “comprise” and variations thereof, such as, “comprises” and “comprising” are to be construed in an open, inclusive sense that is as “including, but not limited to.”
[0026] The recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein.
[0027] All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g. “such as”) provided with respect to certain embodiments herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the invention.
[0028] Groupings of alternative elements or embodiments of the invention disclosed herein are not to be construed as limitations. Each group member can be referred to and claimed individually or in any combination with other members of the group or other elements found herein. One or more members of a group can be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is herein deemed to contain the group as modified.
[0029] The description that follows, and the embodiments described therein, is provided by way of illustration of an example, or examples, of particular embodiments of the principles and aspects of the present disclosure. These examples are provided for the purposes of explanation, and not of limitation, of those principles and of the disclosure.
[0030] It should also be appreciated that the present disclosure can be implemented in numerous ways, including as a system, a method or a device. In this specification, these implementations, or any other form that the invention may take, may be referred to as processes. In general, the order of the steps of the disclosed processes may be altered within the scope of the invention.
[0031] The headings and abstract of the invention provided herein are for convenience only and do not interpret the scope or meaning of the embodiments.
[0032] The following discussion provides many example embodiments of the inventive subject matter. Although each embodiment represents a single combination of inventive elements, the inventive subject matter is considered to include all possible combinations of the disclosed elements. Thus if one embodiment comprises elements A, B, and C, and a second embodiment comprises elements B and D, then the inventive subject matter is also considered to include other remaining combinations of A, B, C, or D, even if not explicitly disclosed.
[0033] As described herein, the term ‘therapeutically effective amount’ refers to the amount of the composition required to bring about a change or improvement in the subject without side effects or overdosing.
[0034] In an embodiment, the present disclosure relates to a nutraceutical tea composition for boosting immunity comprising Phyllanthus emblica, Tinospora cordifolia, Curcuma longa, Citrus limon, Piper nigrum, Cinnamomum verum, Syzygium aromaticum, and Zingiber officinale.
[0035] In an embodiment, the nutraceutical tea composition for boosting immunity comprises Phyllanthus emblica in an amount of about 20% to about 50%, preferably about 40% by weight of the composition.
[0036] In an embodiment, the nutraceutical tea composition for boosting immunity comprises Tinospora cordifolia in an amount of about 10% to about 30%, preferably about 16% by weight of the composition.
[0037] In an embodiment, the nutraceutical tea composition for boosting immunity comprises Curcuma longa in an amount of about 10% to about 30%, preferably about 16% by weight of the composition.
[0038] In an embodiment, the nutraceutical tea composition for boosting immunity comprises Citrus limon in an amount of about 4% to about 20%, preferably about 8% by weight of the composition.
[0039] In an embodiment, the nutraceutical tea composition for boosting immunity comprises Piper nigrum in an amount of about 2.5% to about 15%, preferably about 4% by weight of the composition.
[0040] In an embodiment, the nutraceutical tea composition for boosting immunity comprises Cinnamomum verum in an amount of about 2.5% to about 15%, preferably about 4% by weight of the composition.
[0041] In an embodiment, the nutraceutical tea composition for boosting immunity comprises Syzygium aromaticum in an amount of about 4% to about 20%, preferably about 8% by weight of the composition.
[0042] In an embodiment, the nutraceutical tea composition for boosting immunity comprises of Zingiber officinale in an amount of about 2.5% to about 15%, preferably about 4% by weight of the composition.
[0043] In an embodiment, the nutraceutical tea composition for boosting immunity comprises about 20% to about 50% of Phyllanthus emblica, about 10% to about 30% of Tinospora cordifolia, about 10% to about 30% of Curcuma longa, about 4% to about 20% of Citrus limon, about 2.5% to about 15% of Piper nigrum, about 2.5% to about 15% of Cinnamomum verum, about 4% to about 20% of Syzygium aromaticum, and about 2.5% to about 15% of Zingiber officinale.
[0044] Phyllanthus emblica or amla or Indian gooseberry is one of the most important plants in Indian traditional system of medicine. It is a deciduous shrub or small tree that is primarily grown in the Indian subcontinent. The undemanding plant thrives in regions that are dry and even unsuitable for other crops. The fruits of the plant are consumed both raw and uncooked and possess a strong and sour taste. It is one of the richest sources of Vitamin C and is known to possess anti-pyretic and diuretic properties.
[0045] Tinospora cordifolia or Heart-leaved moonseed or Giloy or Guduchi, is a climbing shrub native to India. It is typically found at higher altitudes and is flower bearing (greenish yellow). A variety of steroids, alkaloids and other active compounds have been isolated and identified from the plant.
[0046] Curcuma longa or turmeric belongs to the ginger family and is a very common spice in India. The rhizomes of the plant are generally used as spice or as a yellow dye. It is a perennial herb that is majorly domesticated. It has long leaves and bears yellow white flowers borne on the stalk. It is extensively used in Indian cooking (as a curry powder) and in ayurveda as anti-inflammatory, anti-septic and anti-oxidant.
[0047] Citrus limon is a small evergreen tree belonging to the family of Rutaceae. Its fruits are exceptionally popular as round yellow lemons used extensively in cooking and other areas. The fruit is bitter but is a rich source of Vitamin C. It is used as an anti-bacterial, astringent and in aromatherapy.
[0048] Piper nigrum or pepper is a flowering climber native to the ghats of Kerala, India. The berry like peppercorn fruit is used as a hot spice or table condiment. It is one of the most widely traded spices. It has almond shaped leaves and bears at its spikes flowers in clusters. It is used as a digestive and is known to cause sneezing.
[0049] Cinnamomum verum or Ceylon cinnamon or cinnamon is an evergreen tree native to south Asian countries, primarily Sri Lanka. The bark is soft in young shoots while it matures into rough, dark brown and thick bark with age. Its fruits are one seeded oval berries. Production of cinnamon spice extracted from the bark as long quills is a labor and cost intensive process. Cinnamon oil from the twigs or leaves is another common by product of the tree.
[0050] Syzygium aromaticum or clove is a traditional spice used in Indian cooking. An essential oil obtained from the plant is also used in flavoring and as topical medicine for toothache, gum infection etc. Clove is the dried flower bud of the evergreen tree. It is commonly cultivated in tropical climates and has flowers that are hermaphrodite and self pollinating.
[0051] Zingiber officinale or ginger is a perennial herb cultivated in tropical climates. The name is indirectly derived from the Sanskrit term ‘shringavera’, which means ‘shaped like a deer’s antlers’. The aromatic spice is used in cooking in Indian kitchens, where young ginger roots are used for its juice and flesh. Some evidence suggests its use for anti-inflammation and anti-spasms.
[0052] In an embodiment, the present disclosure relates to a nutraceutical tea composition for boosting immunity comprising whole Phyllanthus emblica, whole Tinospora cordifolia, whole Curcuma longa, whole Citrus limon, whole Piper nigrum, whole Cinnamomum verum, whole Syzygium aromaticum, and whole Zingiber officinale.
[0053] In an embodiment, the present disclosure relates to a nutraceutical tea composition for boosting immunity comprising an extract of Phyllanthus emblica, an extract of Tinospora cordifolia, an extract of Curcuma longa, an extract of Citrus limon, an extract of Piper nigrum, an extract of Cinnamomum verum, an extract of Syzygium aromaticum, and an extract of Zingiber officinale.
[0054] In an embodiment, the present disclosure relates to a nutraceutical tea composition for boosting immunity comprising a part of Phyllanthus emblica, a part of Tinospora cordifolia, a part of Curcuma longa, a part of Citrus limon, a part of Piper nigrum, a part of Cinnamomum verum, a part of Syzygium aromaticum, and a part of Zingiber officinale.
[0055] In an embodiment, the extract or part may be obtained from the root, leaves, shoot, fruits, rhizome, seed, stem, barks, flower, or bud of the plant.
[0056] In another embodiment, the nutraceutical tea composition for boosting immunity may further comprise an excipient. The excipient may be selected from the group comprising of flavonoids, stabilizers, binders, flavoring agents, coloring agents, humectants, preservatives, olfactory agents, and combinations thereof.
[0057] In an embodiment, the excipient may be selected from the group comprising of benzoates, carbopol, polyethylene glycol, sucrose, lactose, sodium bicarbonate, sodium carbonate, microcrystalline cellulose, methyl cellulose, aspartame, talc, silica powder, and combinations thereof.
[0058] In an embodiment, the composition of the present disclosure may be provided in an oral dosage form, including tablets, powders, gels, granules, concentrates or capsules. These forms may then be added in a tea bag at the time of usage, after crushing, opening and/or sieving, for infusion in a solvent.
[0059] In an embodiment, the composition may be infused in a solvent before consumption by a subject. The solvent is preferably water however, any solvent suitable for consumption may be used provided the same does not interfere with the working of the composition. The infusion of the composition in a solvent is done by keeping the composition dipped in the solvent for about 5 minutes to about 15 minutes. While infusing, the tea may be kept covered.
[0060] In an embodiment, the nutraceutical tea composition may be suitable for boosting immunity against a host of conditions. Preferably, it may increase immunity against respiratory diseases, including but not limited to acute respiratory distress syndrome, SARS, MERS, coronavirus or COVID-19.
[0061] In an embodiment, the composition provides an easy to use, economical and natural method of improving immunity. The said composition also lacks side effects unlike the synthetic compositions known in the art. In an embodiment, the composition does not lead to acidity. Surprisingly, the composition of the present disclosure exhibits synergistic activity.
[0062] In another embodiment, the present disclosure provides a tea bag comprising the nutraceutical tea composition and a means for packaging.
[0063] In an embodiment, the means for packaging may be any suitable material that is porous and allows infusion. The means for packaging may be made from cotton or muslin, cotton silk, jute, nylon, paper, alloy or metal, preferably it is a muslin cloth. The means for packaging must not interfere with the aroma or flavor of the nutraceutical tea composition.
[0064] In a preferred embodiment, the tea bag, comprising the nutraceutical tea composition and the means for packaging, may be made in the form of a poultice or potli. The poultice is dipped in the solvent to be infused with the herbs of the composition, before consumption of the solvent by the subject.
[0065] In yet another embodiment, the present disclosure relates to a process of preparing a nutraceutical tea composition for boosting immunity comprising the steps of:
i) washing and sieving Phyllanthus emblica, Tinospora cordifolia, Curcuma longa, Citrus limon, Piper nigrum, Cinnamomum verum, Syzygium aromaticum, and Zingiber officinale,
ii) mixing and grinding the sieved components of i) to obtain a ground mixture; and
iii) sieving the ground mixture to obtain the nutraceutical tea composition.
[0066] In an embodiment, the process may comprise of steps of sieving, washing, drying, heating, extracting, compacting, grinding or combinations thereof.
[0067] While the foregoing describes various embodiments of the disclosure, other and further embodiments of the disclosure may be devised without departing from the basic scope thereof. The scope of the invention is determined by the claims that follow. The invention is not limited to the described embodiments, versions or examples, which are included to enable a person having ordinary skill in the art to make and use the invention when combined with information and knowledge available to the person having ordinary skill in the art.
[0068] The present invention is further explained in the form of following examples. However, it is to be understood that the following examples are merely illustrative and are not to be taken as limitations upon the scope of the invention.
All the ingredients employed are commercially available ingredients purchased from a local vendor.
[0069] Example 1: Nutraceutical Tea composition:
[0070] Phyllanthus emblica (amla powder) 1g, Tinospora cordifolia (Giloy powder)0.4g, Curcuma longa (turmeric)0.4g, Citrus limon (lemon peel) 0.2g, Piper nigrum (Black pepper) 0.1g, Cinnamomum verum (cinnamom) 0.1g, Syzygium aromaticum( Clove) 0.2g and Zingiber officinale (Dry ginger) 0.1g were mixed properly in pestle mortar to make a homogeneous mixture and were then packed in muslin cloth in potli form.
[0071] In 250 ml boiled water, the potli was kept for about 10 minutes in a closed cover. Water soluble constituents from the composition were extracted into water and consumed as immunity booster. Surprisingly, the composition of the present disclosure exhibits synergistic activity.
[0072] The foregoing examples are merely illustrative and are not to be taken as limitations upon the scope of the invention. Various changes and modifications to the disclosed embodiments will be apparent to those skilled in the art. Such changes and modifications may be made without departing from the scope of the invention.
ADVANTAGES OF THE PRESENT INVENTION
[0073] The present disclosure provides a nutraceutical tea composition that satisfies the existing needs, as well as others, and generally overcomes the deficiencies found in the prior art.
[0074] The present disclosure provides a nutraceutical tea composition that is an immunity booster.
[0075] The present disclosure provides a nutraceutical tea composition that improves respiratory health.
[0076] The present disclosure provides a nutraceutical tea composition that is eco-friendly, cost-effective and easy to produce.
Claims:1. A nutraceutical tea composition for boosting immunity comprising Phyllanthus emblica, Tinospora cordifolia, Curcuma longa, Citrus limon, Piper nigrum, Cinnamomum verum, Syzygium aromaticum, and Zingiber officinale.
2. The composition as claimed in claim 1, comprising whole Phyllanthus emblica, whole Tinospora cordifolia, whole Curcuma longa, whole Citrus limon, whole Piper nigrum, whole Cinnamomum verum, whole Syzygium aromaticum, and whole Zingiber officinale.
3. The composition as claimed in claim 1, comprising an extract of Phyllanthus emblica, an extract of Tinospora cordifolia, an extract of Curcuma longa, an extract of Citrus limon, an extract of Piper nigrum, an extract of Cinnamomum verum, an extract of Syzygium aromaticum, and an extract of Zingiber officinale.
4. The composition as claimed in claim 1, comprising a part of Phyllanthus emblica, a part of Tinospora cordifolia, a part of Curcuma longa, a part of Citrus limon, a part of Piper nigrum, a part of Cinnamomum verum, a part of Syzygium aromaticum, and a part of Zingiber officinale.
5. The composition as claimed in claim 1, wherein Phyllanthus emblica is present in an amount of 20% to 50% by weight of the composition.
6. The composition as claimed in claim 1, wherein Tinospora cordifolia is present in an amount of 10% to 30% by weight of the composition.
7. The composition as claimed in claim 1, wherein Curcuma longa is present in an amount of 10% to 30% by weight of the composition.
8. The composition as claimed in claim 1, wherein Citrus limon is present in an amount of 4% to 20% by weight of the composition.
9. The composition as claimed in claim 1, wherein Piper nigrum is present in an amount of 2.5% to 15% by weight of the composition.
10. The composition as claimed in claim 1, wherein Cinnamomum verum is present in an amount of 2.5% to 15% by weight of the composition.
11. The composition as claimed in claim 1, wherein Syzygium aromaticum is present in an amount of 4% to 20% by weight of the composition.
12. The composition as claimed in claim 1, wherein Zingiber officinale is present in an amount of 2.5% to 15% by weight of the composition.
13. The composition as claimed in claim 1, wherein the composition further comprises excipients.
14. The composition as claimed in claim 13, wherein the excipients are selected from the group comprising of binder, flavouring agent, coloring agent, humectants, preservatives, olfactory agents, and combinations thereof.
15. A tea bag comprising the nutraceutical tea composition as claimed in claim 1 and a means for packaging.
16. A process of preparing a nutraceutical tea composition for boosting immunity comprising the steps of:
i) washing and sieving Phyllanthus emblica, Tinospora cordifolia, Curcuma longa, Citrus limon, Piper nigrum, Cinnamomum verum, Syzygium aromaticum, and Zingiber officinale;
ii) mixing and grinding the sieved components of i) to obtain a ground mixture; and
iii) sieving the ground mixture to obtain the nutraceutical tea composition.
| # | Name | Date |
|---|---|---|
| 1 | 202011036975-PRE GRANT OPPOSITION DOCUMENT [15-12-2022(online)].pdf | 2022-12-15 |
| 1 | 202011036975-STATEMENT OF UNDERTAKING (FORM 3) [27-08-2020(online)].pdf | 2020-08-27 |
| 2 | 202011036975-FORM FOR STARTUP [27-08-2020(online)].pdf | 2020-08-27 |
| 2 | 202011036975-FORM 18 [12-05-2022(online)].pdf | 2022-05-12 |
| 3 | 202011036975-FORM-26 [11-09-2020(online)].pdf | 2020-09-11 |
| 3 | 202011036975-FORM FOR SMALL ENTITY(FORM-28) [27-08-2020(online)].pdf | 2020-08-27 |
| 4 | 202011036975-Proof of Right [11-09-2020(online)].pdf | 2020-09-11 |
| 4 | 202011036975-FORM 1 [27-08-2020(online)].pdf | 2020-08-27 |
| 5 | 202011036975-COMPLETE SPECIFICATION [27-08-2020(online)].pdf | 2020-08-27 |
| 5 | 202011036975-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [27-08-2020(online)].pdf | 2020-08-27 |
| 6 | 202011036975-DECLARATION OF INVENTORSHIP (FORM 5) [27-08-2020(online)].pdf | 2020-08-27 |
| 6 | 202011036975-EVIDENCE FOR REGISTRATION UNDER SSI [27-08-2020(online)].pdf | 2020-08-27 |
| 7 | 202011036975-DECLARATION OF INVENTORSHIP (FORM 5) [27-08-2020(online)].pdf | 2020-08-27 |
| 7 | 202011036975-EVIDENCE FOR REGISTRATION UNDER SSI [27-08-2020(online)].pdf | 2020-08-27 |
| 8 | 202011036975-COMPLETE SPECIFICATION [27-08-2020(online)].pdf | 2020-08-27 |
| 8 | 202011036975-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [27-08-2020(online)].pdf | 2020-08-27 |
| 9 | 202011036975-FORM 1 [27-08-2020(online)].pdf | 2020-08-27 |
| 9 | 202011036975-Proof of Right [11-09-2020(online)].pdf | 2020-09-11 |
| 10 | 202011036975-FORM-26 [11-09-2020(online)].pdf | 2020-09-11 |
| 10 | 202011036975-FORM FOR SMALL ENTITY(FORM-28) [27-08-2020(online)].pdf | 2020-08-27 |
| 11 | 202011036975-FORM FOR STARTUP [27-08-2020(online)].pdf | 2020-08-27 |
| 11 | 202011036975-FORM 18 [12-05-2022(online)].pdf | 2022-05-12 |
| 12 | 202011036975-STATEMENT OF UNDERTAKING (FORM 3) [27-08-2020(online)].pdf | 2020-08-27 |
| 12 | 202011036975-PRE GRANT OPPOSITION DOCUMENT [15-12-2022(online)].pdf | 2022-12-15 |